Trial Profile
Clinical Trials Insight: 700006552
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2005
Price :
$35
*
At a glance
- Drugs GS 9132 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 31 Oct 2005 New trial record.